# A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response

> **NCT01301001** · NA · COMPLETED · sponsor: **University of Tennessee** · enrollment: 230 (actual)

## Conditions studied

- Vulvodynia

## Interventions

- **DRUG:** Placebo oral capsule
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT01301001
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2017-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301001, "A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01301001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*